Variant report
Variant | esv2238332 |
---|---|
Chromosome Location | chr2:36008802-36009250 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs537167211 | chr2:36008802-36008803 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs192313505 | chr2:36008829-36008830 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs35348136 | chr2:36008834-36008835 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs77382817 | chr2:36008864-36008865 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs540948360 | chr2:36008889-36008890 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs559643188 | chr2:36008899-36008900 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs183287616 | chr2:36008900-36008901 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs7579383 | chr2:36008928-36008929 | Weak transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
9 | rs563344129 | chr2:36008960-36008961 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs141781282 | chr2:36008978-36008979 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs530883556 | chr2:36008990-36008991 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs7591804 | chr2:36009012-36009013 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs376501125 | chr2:36009019-36009020 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs561307877 | chr2:36009051-36009052 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs70943139 | chr2:36009053-36009054 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs375263781 | chr2:36009054-36009055 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs149850332 | chr2:36009059-36009060 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs546969586 | chr2:36009060-36009061 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs571870267 | chr2:36009067-36009068 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs9308982 | chr2:36009121-36009122 | Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
21 | rs9308983 | chr2:36009125-36009126 | Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
22 | rs145878975 | chr2:36009129-36009130 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs9308984 | chr2:36009139-36009140 | Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
24 | rs555532437 | chr2:36009172-36009173 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs573754840 | chr2:36009178-36009179 | Strong transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs72873316 | chr2:36009180-36009181 | Strong transcription Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
27 | rs140654099 | chr2:36009200-36009201 | Strong transcription Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs145770398 | chr2:36009242-36009243 | Weak transcription Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Breast cancer | 17393978 | CNVD |
Acute lymphoblastic leukemia | 21098271 | CNVD |
Breast cancer | 17603634 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Diffuse large b-cell lymphoma | 18287131 | CNVD |
Ovarian neoplasms | 16753589 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Neuroblastoma | 17533364 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Adrenal tumor | 17535989 | CNVD |
Breast cancer | 21264507 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Medulloblastoma | 17522785 | CNVD |
Cancer | 23418310 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Ependymoma | 16718352 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
Prostate cancer | 18632612 | CNVD |
Bladder cancer | 21909424 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Hodgkin''s lymphoma | 17606441 | CNVD |
Intellectual disability | 22102821 | CNVD |
Cancer | 20164919 | CNVD |
Hodgkin''s lymphoma | 18641027 | CNVD |
Autism | 22495311 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Follicular lymphoma | 20505157 | CNVD |
Autism | 17483303 | CNVD |
Invasive pancreatic ductal carcinoma | 16982739 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Esophageal adenocarcinoma | 18519675 | CNVD |
Medulloblastoma | 20607354 | CNVD |
Leukemia | 18628472 | CNVD |
Autism | 19521722 | CNVD |
Autism | 18522746 | CNVD |
Breast cancer | 21364760 | CNVD |
Wilms tumour | 21544195 | CNVD |
Non-small cell lung cancer | 18927303 | CNVD |
Hereditary gingival fibromatosis | 19633868 | CNVD |
Breast cancer | 21785460 | CNVD |
Lung cancer | 18438408 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Breast cancer | 21045282 | CNVD |
Prostate cancer | 21965145 | CNVD |
Breast cancer | 16397240 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Neuroblastoma | 21508638 | CNVD |
Neurodevelopmental disorder | 22521361 | CNVD |
Neurocytoma | 17123091 | CNVD |
Autism | 22495309 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Melanoma | 18172304 | CNVD |
Cancer | 16751803 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr2:36008600-36009000 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
2 | chr2:36008600-36009400 | Enhancers | A549 | lung |
3 | chr2:36009000-36009200 | Strong transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |
4 | chr2:36009200-36011800 | Weak transcription | hESC Derived CD184+ Endoderm Cultured Cells | ES cell derived |